Press Releases

Our latest press releases are
available to read here

Press Releases

Date Range

Explore

Search

Press Releases / 04 Jun 2023

Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023

Press Releases / 01 Jun 2023

Ivonescimab Updated Data to be Featured at ASCO 2023

Press Releases / 11 May 2023

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023

Press Releases / 09 May 2023

Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112)

Press Releases / 03 May 2023

Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)

Press Releases / 09 Mar 2023

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022

Press Releases / 03 Mar 2023

Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering

Press Releases / 23 Feb 2023

Summit Therapeutics’ Rights Offering Nearing Expiration Date

Press Releases / 30 Jan 2023

Summit Therapeutics Announces Timing of Rights Offering for Up to $500 Million

Press Releases / 20 Jan 2023

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Press Releases / 05 Jan 2023

Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Press Releases / 06 Dec 2022

Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody

1 2 … 31 32 >>

Website Cookies

This website uses cookies: Please see our Privacy Policy to understand how we use cookies.